XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Total Stockholders Equity
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Non-Redeemable Noncontrolling Interests in Subsidiaries
Balance at beginning of period (in shares) at Dec. 31, 2021     132.0        
Balance at beginning of period at Dec. 31, 2021   $ 1,259 $ 1 $ 515 $ 1,031 $ (291) $ 3
Comprehensive income:              
Net income (loss)   (35)     (34)   (1)
Other comprehensive income (loss) $ 18 18       18  
Total comprehensive income (loss)   (17)     (34) 18  
Total comprehensive income (loss), attributable to nonredeemable noncontrolling interest             (1)
Employee stock purchase and stock compensation plans (in shares)     3.0        
Employee stock purchase and stock compensation plans   19   19      
Series A convertible preferred stock dividends   (4)     (4)    
Stock issued in acquisition of LibertyX (in shares)     1.0        
Stock issued in acquisition of LibertyX   68   68      
Balance at end of period (in shares) at Mar. 31, 2022     136.0        
Balance at end of period at Mar. 31, 2022   1,325 $ 1 602 993 (273) 2
Balance at beginning of period (in shares) at Dec. 31, 2022 138.0   138.0        
Balance at beginning of period at Dec. 31, 2022 $ 1,479 1,479 $ 1 704 1,075 (300) (1)
Comprehensive income:              
Net income (loss)   10     9   1
Other comprehensive income (loss) $ (20) (20)       (19) (1)
Total comprehensive income (loss)   (10)     9 (19)  
Total comprehensive income (loss), attributable to nonredeemable noncontrolling interest             0
Employee stock purchase and stock compensation plans (in shares)     2.0        
Employee stock purchase and stock compensation plans   23   23      
Series A convertible preferred stock dividends   (4)     (4)    
Balance at end of period (in shares) at Mar. 31, 2023 140.1   140.0        
Balance at end of period at Mar. 31, 2023 $ 1,488 $ 1,488 $ 1 $ 727 $ 1,080 $ (319) $ (1)